Germany's Neovii Biotech and India's VINS Bioproducts will explore collaboration on manufacturing and commercialising immunoglobulin products, including anti-thymocyte globulin used in organ transplantation and certain blood disorders. Facilitated by the Indian Embassy in Berlin, the agreement involves technology transfer to India and could strengthen domestic capabilities in specialised biological products.
Indian, German firms to collaborate on immunoglobulin products: Indian Embassy
Germany's Neovii Biotech and India's VINS Bioproducts will explore collaboration on manufacturing and commercialising im...
By Dhallo News · October 16, 2026 at 1:28 PM IST
Source: Economic Times - Healthcare
SOURCE: Economic Times - Healthcare
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion
